Innovating Works

MSH

Desconocido
AtheroGLP1: Unmasking the molecular mechanisms mediating the antiatherogenic effects of GLP-1RAs Mount Sinai Hospital participó en un HORIZON EUROPE: HORIZON-MSCA-2022-PF-01 Cardiovascular diseases (CVD) are highly prevalent in Europe, causing more than 3.9 million deaths yearly. Atherosclerosis, a chronic inflam...
2023-03-14 - 2027-08-31 | Financiado
RISEinFAMILY: Alliance for Family Integrated Care FICare Implementation in Neonatal Intensive Care Units Mount Sinai Hospital participó en un H2020: H2020-MSCA-RISE-2020 Preterm births are the major cause of infant mortality in both developed and developing worldwide countries and one of the main concerns of...
2020-10-13 - 2025-12-31 | Financiado
SATBIOFUN: Genome editing for spatiotemporal analysis of centriolar SATellite BIOgenesis and FUNction in cellul... Mount Sinai Hospital participó en un H2020: H2020-MSCA-IF-2015 The centrosome is the major microtubule-organizing centre of a cell. It also serves as the base for the primary cilium, an antenna-like stru...
2016-02-19 - 2019-06-30 | Financiado
CREATE: Coordination of resources for conditional expression of mutated mouse alleles Mount Sinai Hospital participó en un FP7: This proposal describes CREATE, an internationally based Coordination Action directly addressing a large scale data gathering activity for s...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.